nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—periodontitis	0.799	1	CbGaD
Clodronate—SLC25A6—mouth—periodontitis	0.0171	0.122	CbGeAlD
Clodronate—SLC25A6—Influenza Virus Induced Apoptosis—TGFB1—periodontitis	0.0161	0.268	CbGpPWpGaD
Clodronate—SLC25A5—mouth—periodontitis	0.0149	0.106	CbGeAlD
Clodronate—SLC25A6—neck—periodontitis	0.0146	0.104	CbGeAlD
Clodronate—SLC25A5—neck—periodontitis	0.0127	0.0905	CbGeAlD
Clodronate—SLC25A5—trigeminal ganglion—periodontitis	0.011	0.0781	CbGeAlD
Clodronate—SLC25A6—connective tissue—periodontitis	0.0105	0.0746	CbGeAlD
Clodronate—SLC25A5—parotid gland—periodontitis	0.0104	0.0737	CbGeAlD
Clodronate—SLC25A6—epithelium—periodontitis	0.00995	0.0708	CbGeAlD
Clodronate—PTGS2—periosteum—periodontitis	0.00984	0.0701	CbGeAlD
Clodronate—SLC25A5—connective tissue—periodontitis	0.00911	0.0649	CbGeAlD
Clodronate—SLC25A5—epithelium—periodontitis	0.00865	0.0616	CbGeAlD
Clodronate—SLC25A6—Host Interactions with Influenza Factors—TGFB1—periodontitis	0.00772	0.129	CbGpPWpGaD
Clodronate—PTGS2—endothelium—periodontitis	0.00363	0.0258	CbGeAlD
Clodronate—PTGS2—mouth—periodontitis	0.0028	0.0199	CbGeAlD
Clodronate—PTGS2—trigeminal ganglion—periodontitis	0.00207	0.0147	CbGeAlD
Clodronate—PTGS2—connective tissue—periodontitis	0.00172	0.0122	CbGeAlD
Clodronate—PTGS2—epithelium—periodontitis	0.00163	0.0116	CbGeAlD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL13—periodontitis	0.00151	0.0251	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00132	0.0219	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC52A3—periodontitis	0.0011	0.0183	CbGpPWpGaD
Clodronate—PTGS2—Eicosanoid Synthesis—GGT1—periodontitis	0.00101	0.0168	CbGpPWpGaD
Clodronate—SLC25A5—Disease—SLC52A3—periodontitis	0.00101	0.0168	CbGpPWpGaD
Clodronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—periodontitis	0.000981	0.0163	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1A—periodontitis	0.000949	0.0158	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL10—periodontitis	0.000943	0.0157	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—CRP—periodontitis	0.000845	0.0141	CbGpPWpGaD
Clodronate—SLC25A6—Disease—SLC52A3—periodontitis	0.000843	0.014	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—SLC52A3—periodontitis	0.000843	0.014	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—SLC52A3—periodontitis	0.000706	0.0118	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—periodontitis	0.000697	0.0116	CbGpPWpGaD
Clodronate—SLC25A5—Disease—LTF—periodontitis	0.000684	0.0114	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SLC52A3—periodontitis	0.000658	0.011	CbGpPWpGaD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—periodontitis	0.000648	0.0108	CbGpPWpGaD
Clodronate—SLC25A5—Disease—ACP5—periodontitis	0.000593	0.00987	CbGpPWpGaD
Clodronate—SLC25A6—Disease—LTF—periodontitis	0.000573	0.00954	CbGpPWpGaD
Clodronate—PTGS2—Arachidonic acid metabolism—GGT1—periodontitis	0.000561	0.00935	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SLC52A3—periodontitis	0.000551	0.00918	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—CXCL8—periodontitis	0.00055	0.00915	CbGpPWpGaD
Clodronate—SLC25A6—Influenza Infection—TGFB1—periodontitis	0.000534	0.00889	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.000516	0.00858	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ACP5—periodontitis	0.000497	0.00827	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—ACP5—periodontitis	0.000497	0.00827	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL1B—periodontitis	0.000495	0.00824	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—MPO—periodontitis	0.000489	0.00814	CbGpPWpGaD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—periodontitis	0.000473	0.00787	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—MPO—periodontitis	0.000471	0.00784	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—periodontitis	0.000451	0.0075	CbGpPWpGaD
Clodronate—SLC25A4—Disease—LTF—periodontitis	0.000448	0.00745	CbGpPWpGaD
Clodronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—periodontitis	0.000421	0.00701	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ACP5—periodontitis	0.000416	0.00693	CbGpPWpGaD
Clodronate—SLC25A4—Disease—ACP5—periodontitis	0.000388	0.00646	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—TNF—periodontitis	0.000383	0.00637	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—FCGR2A—periodontitis	0.000377	0.00628	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TNF—periodontitis	0.000359	0.00598	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—GGT1—periodontitis	0.000357	0.00595	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCR2—periodontitis	0.000327	0.00545	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ACP5—periodontitis	0.000325	0.00541	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MMP1—periodontitis	0.000315	0.00525	CbGpPWpGaD
Clodronate—PTGS2—Overview of nanoparticle effects—IL6—periodontitis	0.000309	0.00514	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—IL6—periodontitis	0.00029	0.00482	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GGT1—periodontitis	0.000276	0.0046	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—periodontitis	0.000273	0.00454	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CCL2—periodontitis	0.000256	0.00427	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—periodontitis	0.000253	0.00422	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CRP—periodontitis	0.000248	0.00413	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP1—periodontitis	0.000246	0.0041	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—MMP2—periodontitis	0.000244	0.00406	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1A—periodontitis	0.000235	0.0039	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—GGT1—periodontitis	0.000232	0.00385	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL4—periodontitis	0.000227	0.00378	CbGpPWpGaD
Clodronate—SLC25A5—Disease—NOS2—periodontitis	0.000209	0.00348	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—CCL2—periodontitis	0.000204	0.00339	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—CXCL8—periodontitis	0.000203	0.00337	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CCL2—periodontitis	0.0002	0.00333	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PPARA—periodontitis	0.000198	0.00329	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—MMP2—periodontitis	0.00019	0.00317	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—periodontitis	0.000189	0.00314	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TLR4—periodontitis	0.000188	0.00313	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—periodontitis	0.000181	0.00302	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GGT1—periodontitis	0.000181	0.00301	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—NOS2—periodontitis	0.000179	0.00298	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—periodontitis	0.000176	0.00294	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NOS2—periodontitis	0.000175	0.00291	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IFNG—periodontitis	0.000173	0.00289	CbGpPWpGaD
Clodronate—SLC25A5—Disease—FGF2—periodontitis	0.00017	0.00283	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PPARA—periodontitis	0.000166	0.00276	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CCL2—periodontitis	0.000161	0.00268	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—CXCL8—periodontitis	0.000158	0.00263	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL1B—periodontitis	0.000155	0.00257	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTGS2—periodontitis	0.000154	0.00256	CbGpPWpGaD
Clodronate—SLC25A6—Disease—FGF2—periodontitis	0.000143	0.00237	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IFNG—periodontitis	0.000137	0.00228	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS2—periodontitis	0.000137	0.00227	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC52A3—periodontitis	0.00013	0.00217	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARA—periodontitis	0.000129	0.00215	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PTGS2—periodontitis	0.000129	0.00214	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PTGS2—periodontitis	0.000129	0.00214	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CXCL8—periodontitis	0.000127	0.00212	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL1B—periodontitis	0.000122	0.00204	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MMP9—periodontitis	0.000115	0.00192	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—periodontitis	0.000112	0.00187	CbGpPWpGaD
Clodronate—SLC25A4—Disease—FGF2—periodontitis	0.000111	0.00185	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—periodontitis	0.000111	0.00185	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC52A3—periodontitis	0.000109	0.00181	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—periodontitis	0.000108	0.00179	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—periodontitis	0.0001	0.00167	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—periodontitis	9.91e-05	0.00165	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—periodontitis	9.5e-05	0.00158	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—periodontitis	9.3e-05	0.00155	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—periodontitis	9.06e-05	0.00151	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—periodontitis	8.87e-05	0.00148	CbGpPWpGaD
Clodronate—PTGS2—Disease—LTF—periodontitis	8.85e-05	0.00147	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—periodontitis	8.41e-05	0.0014	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—periodontitis	8.36e-05	0.00139	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GGT1—periodontitis	8.02e-05	0.00134	CbGpPWpGaD
Clodronate—PTGS2—Disease—ACP5—periodontitis	7.67e-05	0.00128	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—periodontitis	7.26e-05	0.00121	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—periodontitis	7.16e-05	0.00119	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—periodontitis	7.01e-05	0.00117	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—periodontitis	6.47e-05	0.00108	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACP5—periodontitis	6.42e-05	0.00107	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—periodontitis	6.04e-05	0.001	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—periodontitis	5.74e-05	0.000956	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—periodontitis	5.47e-05	0.000911	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GGT1—periodontitis	3.57e-05	0.000595	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS2—periodontitis	2.7e-05	0.000449	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARA—periodontitis	2.56e-05	0.000426	CbGpPWpGaD
Clodronate—PTGS2—Disease—FGF2—periodontitis	2.2e-05	0.000366	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—periodontitis	1.44e-05	0.000239	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—periodontitis	1.08e-05	0.00018	CbGpPWpGaD
